Search

Louis V. Wollenberger

Examiner (ID: 3795)

Most Active Art Unit
1635
Art Unit(s)
1635
Total Applications
262
Issued Applications
31
Pending Applications
47
Abandoned Applications
184

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7281277 [patent_doc_number] => 20040063654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Methods and compositions for therapeutic use of RNA interference' [patent_app_type] => new [patent_app_number] => 10/440506 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24879 [patent_no_of_claims] => 231 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063654.pdf [firstpage_image] =>[orig_patent_app_number] => 10440506 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/440506
Methods and compositions for therapeutic use of RNA interference May 14, 2003 Abandoned
Array ( [id] => 6830354 [patent_doc_number] => 20030181412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses' [patent_app_type] => new [patent_app_number] => 10/438151 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 22409 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181412.pdf [firstpage_image] =>[orig_patent_app_number] => 10438151 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/438151
Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses May 13, 2003 Abandoned
Array ( [id] => 7673341 [patent_doc_number] => 20040180438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Methods and compositions for silencing genes without inducing toxicity' [patent_app_type] => new [patent_app_number] => 10/425006 [patent_app_country] => US [patent_app_date] => 2003-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 34069 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180438.pdf [firstpage_image] =>[orig_patent_app_number] => 10425006 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/425006
Methods and compositions for silencing genes without inducing toxicity Apr 27, 2003 Abandoned
Array ( [id] => 7444237 [patent_doc_number] => 20040009510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Allosteric nucleic acid sensor molecules' [patent_app_type] => new [patent_app_number] => 10/422050 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 47542 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009510.pdf [firstpage_image] =>[orig_patent_app_number] => 10422050 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/422050
Allosteric nucleic acid sensor molecules Apr 22, 2003 Abandoned
Array ( [id] => 7367395 [patent_doc_number] => 20040006036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Silencing transcription by methylation' [patent_app_type] => new [patent_app_number] => 10/422466 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15884 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006036.pdf [firstpage_image] =>[orig_patent_app_number] => 10422466 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/422466
Silencing transcription by methylation Apr 21, 2003 Abandoned
Array ( [id] => 7463683 [patent_doc_number] => 20040053289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Short interfering nucleic acid hybrids and methods thereof' [patent_app_type] => new [patent_app_number] => 10/410220 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7824 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053289.pdf [firstpage_image] =>[orig_patent_app_number] => 10410220 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/410220
Short interfering nucleic acid hybrids and methods thereof Apr 7, 2003 Abandoned
Array ( [id] => 6678462 [patent_doc_number] => 20030228603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Compositions selective for caffeine or aspartame and methods of using same' [patent_app_type] => new [patent_app_number] => 10/406903 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 45168 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228603.pdf [firstpage_image] =>[orig_patent_app_number] => 10406903 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/406903
Compositions selective for caffeine or aspartame and methods of using same Apr 2, 2003 Abandoned
Array ( [id] => 7398978 [patent_doc_number] => 20040023265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Methods and compositions for nucleic acid ligands against Shiga toxin and/or Shiga-like toxin' [patent_app_type] => new [patent_app_number] => 10/386778 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13802 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023265.pdf [firstpage_image] =>[orig_patent_app_number] => 10386778 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/386778
Methods and compositions for nucleic acid ligands against Shiga toxin and/or Shiga-like toxin Mar 10, 2003 Abandoned
Array ( [id] => 7364441 [patent_doc_number] => 20040005593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Novel method for delivery and intracellular synthesis of siRNA molecules' [patent_app_type] => new [patent_app_number] => 10/383835 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7327 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005593.pdf [firstpage_image] =>[orig_patent_app_number] => 10383835 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/383835
Novel method for delivery and intracellular synthesis of siRNA molecules Mar 5, 2003 Abandoned
Array ( [id] => 7363879 [patent_doc_number] => 20040005546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Use of ribozymes in the detection of adventitious agents' [patent_app_type] => new [patent_app_number] => 10/375700 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7778 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005546.pdf [firstpage_image] =>[orig_patent_app_number] => 10375700 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/375700
Use of ribozymes in the detection of adventitious agents Feb 25, 2003 Abandoned
Array ( [id] => 7105093 [patent_doc_number] => 20050107316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent' [patent_app_type] => utility [patent_app_number] => 10/505482 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 27137 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107316.pdf [firstpage_image] =>[orig_patent_app_number] => 10505482 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/505482
Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent Feb 20, 2003 Abandoned
Array ( [id] => 7169504 [patent_doc_number] => 20050202428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Pluripotential stem cells' [patent_app_type] => utility [patent_app_number] => 10/504173 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19166 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202428.pdf [firstpage_image] =>[orig_patent_app_number] => 10504173 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/504173
Pluripotential stem cells Feb 11, 2003 Abandoned
Array ( [id] => 7363473 [patent_doc_number] => 20040014956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Double-stranded oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/357529 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25633 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014956.pdf [firstpage_image] =>[orig_patent_app_number] => 10357529 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/357529
Double-stranded oligonucleotides Feb 2, 2003 Abandoned
Array ( [id] => 7287161 [patent_doc_number] => 20040147027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Complex for facilitating delivery of dsRNA into a cell and uses thereof' [patent_app_type] => new [patent_app_number] => 10/353902 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8738 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147027.pdf [firstpage_image] =>[orig_patent_app_number] => 10353902 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/353902
Complex for facilitating delivery of dsRNA into a cell and uses thereof Jan 27, 2003 Abandoned
Array ( [id] => 7393836 [patent_doc_number] => 20040038322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Potentiation of cancer therapies by ZNF217 inhibition' [patent_app_type] => new [patent_app_number] => 10/349627 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 40064 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038322.pdf [firstpage_image] =>[orig_patent_app_number] => 10349627 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/349627
Potentiation of cancer therapies by ZNF217 inhibition Jan 21, 2003 Abandoned
Array ( [id] => 6834727 [patent_doc_number] => 20030162273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Modulation of sulfate permease for photosynthetic hydrogen production' [patent_app_type] => new [patent_app_number] => 10/350298 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 20444 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162273.pdf [firstpage_image] =>[orig_patent_app_number] => 10350298 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/350298
Modulation of sulfate permease for photosynthetic hydrogen production Jan 21, 2003 Abandoned
Array ( [id] => 7322274 [patent_doc_number] => 20040136960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Devices and processes for distribution of genetic material to mammalian limb' [patent_app_type] => new [patent_app_number] => 10/339935 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11716 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20040136960.pdf [firstpage_image] =>[orig_patent_app_number] => 10339935 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/339935
Devices and processes for distribution of genetic material to mammalian limb Jan 9, 2003 Abandoned
Array ( [id] => 6856723 [patent_doc_number] => 20030130224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene' [patent_app_type] => new [patent_app_number] => 10/339934 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13583 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130224.pdf [firstpage_image] =>[orig_patent_app_number] => 10339934 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/339934
Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene Jan 9, 2003 Abandoned
Array ( [id] => 6856723 [patent_doc_number] => 20030130224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene' [patent_app_type] => new [patent_app_number] => 10/339934 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13583 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130224.pdf [firstpage_image] =>[orig_patent_app_number] => 10339934 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/339934
Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene Jan 9, 2003 Abandoned
Array ( [id] => 7398672 [patent_doc_number] => 20040023239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Method of rna cleavage' [patent_app_type] => new [patent_app_number] => 10/296574 [patent_app_country] => US [patent_app_date] => 2003-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8516 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023239.pdf [firstpage_image] =>[orig_patent_app_number] => 10296574 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/296574
Method of rna cleavage Jan 6, 2003 Abandoned
Menu